PTRME

R&D

The field of regenerative medicine is advancing rapidly, offering transformative solutions for a wide range of health conditions.

News

Shares in Tenax 85% of their value after its drug for patients with pulmonary hypertension caused by a form of heart failure flunked a phase 3 trial.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.